跳至主要内容
临床试验/ISRCTN12008159
ISRCTN12008159已完成未知

The effect of increased sodium intake with a carbohydrate-rich meal on glucose homeostasis in subjects without diabetes after bariatric surgery: A proof-of-concept, randomised, open-label, crossover study

niversity of Leicester0 个研究点目标入组 12 人开始时间: 2020年7月23日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged >=18 years old but less than 75 years old
  • 2. Subjects >=1 year after gastric bypass (RYGB)
  • 3. Able to understand written and spoken English
  • 4. Able to give informed consent

排除标准

  • 1. Use of any glucose-lowering medication (including insulin)
  • 2. Adrenal insufficiency and/or substitution with glucocorticoids
  • 3. eGFR <=60 ml/min/173 m²
  • 4. Recent active infection (an active infection will be any infection over the last 10 days)
  • 5. Current use of steroids
  • 6. Known liver cirrhosis or ALT >2 times above upper normal limit
  • 7. Known primary or secondary hyperaldosteronism
  • 8. Moderate or severe hypertension during screening visit (Systolic Blood Pressure >160 mmHg as average of 3 measurements)
  • 9. Established diagnosis of congestive heart failure
  • 10. Significant peripheral oedema on clinical examination at screening visit
  • 11. People with allergy or intolerance to the mixed meal tolerance test (eg, milk protein allergy, lactose and gluten intolerance)
  • 12. People following a vegan diet (mixed meal tolerance test not suitable for those following a vegan diet)
  • 13. Other bariatric procedure except of RYGB
  • 14. Previous revisional bariatric surgery
  • 15. Currently pregnant or breastfeeding
  • 16. Patients with history of Type 1 or Type 2 Diabetes
  • 17. Patients with diagnosis of Epilepsy
  • 18. HbA1C >=65% or >=48 mmol/l at screening blood tests
  • 19. Haemoglobin (Hb) <100 g/l at screening blood tests
  • 20. Participating in another research study involving intervention within 3 months of screening
  • 21. Having a formal previous diagnosis of postprandial hypoglycaemia
  • 22. Being on acarbose, diazoxide, octreotide or other treatment for postprandial hypoglycaemia
  • 23. Any concurrent condition, in the judgment of investigator and/or sponsor, that could interfere with the safety and study conduct or interpretation of study results

研究者

发起方
niversity of Leicester

相似试验